NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

TABLES

Table 1.	Ongoing Randomized Controlled Trials on Hemoglobin Targets in Adult Patients with CKD Identified from Clinicaltrials.gov
Table 2.	Summary Table of RCTs Comparing Different Hb Targets on Key Clinical Outcomes in the HD-CKD and PD-CKD Populations
Table 3.	Summary Table of RCTs Comparing Different Hb Targets on Quality of Life in the HD-CKD and PD-CKD Populations
Table 4.	Summary Table of RCTs Comparing Different Hb Targets on Non-CVD/Mortality Adverse Event Rates in the HD-CKD and PD-CKD Populations
Table 5.	Summary Table of RCTs Comparing Different Hb Targets on Exercise Capacity in the HD-CKD and PD-CKD Populations
Table 6.	Evidence Matrix of Study Quality by Outcome for RCTs Comparing Different Hb Targets in the HD-CKD and PD-CKD Populations
Table 7.	Evidence Profile of RCTs Comparing Different Hb Targets in the HD-CKD and PD-CKD Populations
Table 8.	Summary Table of RCTs Comparing Different Hb Targets on Key Clinical Outcomes in the ND-CKD Population
Table 9.	Summary Table of RCTs Comparing Different Hb Targets on Quality of Life in the ND-CKD Population
Table 10.	Summary Table of RCTs Comparing Different Hb Targets on Non-CVD/Mortality Adverse Event Rates in the ND-CKD Population
Table 11.	Evidence Matrix of Study Quality by Outcome for RCTs Comparing Different Hb Targets in the ND-CKD Population
Table 12.	Evidence Profile of RCTs Comparing Different Hb Targets in the ND-CKD Population
Table 13.	Consideration for Appraisal of Surrogate Outcome Trials
Table 14.	Grading of Study Quality
Table 15.	GRADE System for Grading Quality of Evidence
Table 16.	Strength of Guideline Recommendations, Consensus-Based Statements, and Linkage to Quality of Evidence

FIGURES

Figure 1.	Randomized Controlled Trials Comparing Lower with Higher Hemoglobin (Hb) Target Levels
Figure 2.	Relative Mortality Risk for Assignment to Higher Hemoglobin (Hb) Treatment Targets in Patients with Nondialysis Chronic Kidney Disease
Figure 3.	Relative Risk of Adverse Cardiovascular Events for Assignment to Higher Hemoglobin (Hb) Treatment Target in Patients with Nondialysis Chronic Kidney Disease
Figure 4.	Relative Mortality Risk for Assignment to Higher Hemoglobin (Hb) Treatment Target in Patients with Chronic Kidney Disease Undergoing Dialysis
Figure 5.	Relative Risk of Adverse Cardiovascular Events for Assignment to Higher Hemoglobin (Hb) Treatment Target in Patients with Chronic Kidney Disease Undergoing Dialysis

Back to top | Main Page